| Bioactivity | Anti-Mouse NKG2D/CD314 Antibody (CX5) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse NKG2D/CD314. |
| Invitro | 抗体框架具有稳定性、特异性和适应性，同时具有结合抗原和内源免疫受体。 单克隆抗体具有几种衍生物，包括双特异性抗体、抗体-药物缀合物和抗体片段，在免疫学和肿瘤学等领域具有显著效果。 设计抑制性抗体时，需要注意包括抗原特异性可变区的鉴定、表达系统的选择、多特异性形式的使用以及基于片段化、寡聚化或与其他功能部分缀合的抗体衍生物[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Anti-Mouse NKG2D/CD314 Antibody (CX5) 相关抗体: |
| Molar Mass | 150000.00 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Goulet DR, Atkins WM. Considerations for the Design of Antibody-Based Therapeutics. J Pharm Sci. 2020 Jan;109(1):74-103. |
Anti-Mouse NKG2D/CD314 Antibody (CX5)
CAS: F: W: 150000.00
Anti-Mouse NKG2D/CD314 Antibody (CX5) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse NKG2D/CD314.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.